Influence of SLCO1B1 polymorphisms on lopinavir C trough in Serbian HIV/AIDS patients-Reference-Cited by-同舟云学术

Influence of SLCO1B1 polymorphisms on lopinavir C trough in Serbian HIV/AIDS patients

Published:2020-02-28 Issue:7 Volume:86 Page:1289-1295
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Dragović Gordana¹^ORCID,Dimitrijević Božana¹^ORCID,Kušić Jovana¹^ORCID,Soldatović Ivan²^ORCID,Jevtović Djordje³^ORCID,Olagunju Adeniyi⁴^ORCID,Owen Andrew⁵^ORCID

Affiliation:

1. Department of Pharmacology, Clinical Pharmacology and Toxicology, School of MedicineUniversity of Belgrade Belgrade Serbia

2. Institute for Biomedical Statistics, School of MedicineUniversity of Belgrade Belgrade Serbia

3. Infectious and Tropical Diseases Hospital, School of MedicineUniversity of Belgrade Belgrade Serbia

4. Faculty of PharmacyObafemi Awolowo University Ile‐Ife Nigeria

5. Department of Molecular and Clinical PharmacologyUniversity of Liverpool Liverpool UK

Funder

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14230

Reference43 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Determinants of survival following HIV-1 seroconversion after the introduction of HAART

3. Host determinants of antiretroviral drug activity

4. Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support

5. Low Trough Plasma Concentrations of Nevirapine Associated with Virologic Rebounds in HIV-Infected Patients Who Switched from Protease Inhibitors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV;Pediatric Infectious Disease Journal;2023-07-20

2. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen;British Journal of Clinical Pharmacology;2023-05-12

3. The role of pharmacogenetics in Efficacy and safety of protease inhibitor based therapy in human immunodeficiency virus type (HIV) infection.;Acta Biomedica Scientifica;2021-12-28

4. The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation;European Journal of Clinical Pharmacology;2021-01-02